ArticleJCO precision oncology2024

Targeted-Agent Continual Reassessment Method: A Novel Bayesian Enrichment Design for Phase I Trials of Molecularly Targeted Therapies.

Clement Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.